|
obsolete long-chain-enoyl-CoA hydratase activity
|
GO_0016508 |
[OBSOLETE. Catalysis of the reaction: a medium-chain (3S)-3-hydroxyacyl-CoA = a medium-chain (2E)-enoyl-CoA + H2O. A long-chain acyl-CoA is an acyl-CoA thioester where the acyl chain contains 13 to 22 carbon atoms.] |
|
mitochondrial fatty acid beta-oxidation multienzyme complex
|
GO_0016507 |
[A multienzyme complex possessing three activities in two subunits (alpha and beta) that catalyzes three steps of the fatty acid beta-oxidation cycle within the mitochondrial matrix. The alpha subunit comprises the enoyl-CoA hydratase (ECH) and 3-hydroxyacyl-CoA dehydrogenase (HACD) activities, and the beta subunit contains the acetyl-CoA C-acyltransferase (KACT)/thiolase activity.] |
|
interleukin-12 receptor activity
|
GO_0016517 |
[Combining with interleukin-12 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
interleukin-4 receptor complex
|
GO_0016516 |
[A protein complex that binds interleukin-4 (IL-4) and consists of an alpha chain that binds IL-4 with high affinity and a gamma common chain that also forms part of the interleukin-2 receptor.] |
|
interleukin-13 receptor activity
|
GO_0016515 |
[Combining with interleukin-13 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
SWI/SNF complex
|
GO_0016514 |
[A SWI/SNF-type complex that contains 8 to 14 proteins, including both conserved (core) and nonconserved components; contains the ATPase product of the yeast SNF2 or mammalian SMARCA4/BAF190A/BRG1 gene, or an ortholog thereof.] |
|
core-binding factor complex
|
GO_0016513 |
[A heterodimeric transcription factor complex that contains an alpha subunit (Runx1, Runx2 or Runx3 in human) that binds DNA and a non-DNA-binding beta subunit (CBFbeta), and binds to a consensus sequence 5'-YGYGGTY-3' found in several enhancers and promoters; the beta subunit enhances the DNA binding of the alpha subunit.] |
|
obsolete endothelin-converting enzyme 1 activity
|
GO_0016512 |
[OBSOLETE. Catalysis of the formation of endothelin 1 by cleavage of the Trp21-Val22 bond in the precursor.] |
|
obsolete endothelin-converting enzyme activity
|
GO_0016511 |
[OBSOLETE. (Was not defined before being made obsolete).] |
|
GO_0016510
|
GO_0016510 |
|
|
gastric inhibitory peptide receptor activity
|
GO_0016519 |
[Combining with gastric inhibitory peptide (GIP) and transmitting the signal across the membrane to activate an associated G-protein.] |
|
obsolete interleukin-14 receptor activity
|
GO_0016518 |
[OBSOLETE. Combining with interleukin-14 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
sarcoplasm
|
GO_0016528 |
[The cytoplasm of a muscle cell; includes the sarcoplasmic reticulum.] |
|
obsolete brain-specific angiogenesis inhibitor activity
|
GO_0016527 |
[OBSOLETE. (Was not defined before being made obsolete).] |
|
GO_0016526
|
GO_0016526 |
|
|
latrotoxin receptor activity
|
GO_0016524 |
[Combining with alpha-latrotoxin, a potent presynaptic neurotoxin, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.] |
|
GO_0016523
|
GO_0016523 |
|
|
GO_0016522
|
GO_0016522 |
|
|
pituitary adenylate cyclase activating polypeptide activity
|
GO_0016521 |
[The action characteristic of pituitary adenylate cyclase activating polypeptide, a peptide produced in the hypothalamus that binds to receptors to exert pleiotropic effects including control of neurotransmitter release, vasodilation, bronchodilation, activation of intestinal motility, increase in insulin and histamine secretion, immune modulation, and stimulation of cell proliferation and differentiation.] |
|
growth hormone-releasing hormone receptor activity
|
GO_0016520 |
[Combining with growth hormone-releasing hormone to initiate a change in cell activity.] |